DISCOVERIES OF GENE EDITING USING CRISPR-CAS9 FOR THE TREATMENT OF SICKLE CELL DISEASE: A LITERATURE REVIEW
Introduction/objectives: Sickle cell disease (SCD) is the most common monogenic blood disorder worldwide, causing reduced life expectancy to the patients. The innovative CRISPR-Cas9 gene-editing technology, pioneered by Jennifer Doudna and Emmanuelle Charpentier, has emerged as a potential curative...
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2024-10-01
|
| Saila: | Hematology, Transfusion and Cell Therapy |
| Sarrera elektronikoa: | http://www.sciencedirect.com/science/article/pii/S2531137924023253 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|